Product Information
OMEPRAZOLE DR 10 MG CAPSULE is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.0766 per EA under NDC 68462039501. Its NADAC has been published 515 times since Nov 23, 2016.
FDA first approved this application on Oct 31, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462039501
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OMEPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA091672FDA Approved
10/31/2014
TE Code
AB
On Market Since
10/31/2014
Pharmacological Classes
Price Statistics
The NADAC for OMEPRAZOLE DR 10 MG CAPSULE has been published 515 times since Nov 23, 2016, and over the history we have for it it has declined 73.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0766 per EA |
|---|---|
| All-time high | $0.3132 (Jan 11, 2017) |
| All-time low | $0.0649 (Jul 17, 2024) |
| 52-week high | $0.0816 |
| 52-week low | $0.0694 |
| Median price | $0.1005 |
| Average price | $0.1357 |
| Largest weekly change | +85.4% (Nov 20, 2019) |
| Weeks tracked | 515 |
| Tracking since | Nov 23, 2016 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Omeprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OMEPRAZOLE DR 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OMEPRAZOLE DR 10 MG CAPSULE, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.0766 per EA (NDC 68462039501), effective Sep 30, 2026.
How has the price of OMEPRAZOLE DR 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OMEPRAZOLE DR 10 MG CAPSULE has declined 73.7%. It has been tracked across 515 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for OMEPRAZOLE DR 10 MG CAPSULE?
Since Nov 23, 2016, the NADAC for OMEPRAZOLE DR 10 MG CAPSULE has ranged from a low of $0.0649 (Jul 17, 2024) to a high of $0.3132 (Jan 11, 2017), with a median of $0.1005 per EA.
Are there cheaper alternatives to OMEPRAZOLE DR 10 MG CAPSULE?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OMEPRAZOLE DR 10 MG CAPSULE, is $0.0680 per EA — about 11% below OMEPRAZOLE DR 10 MG CAPSULE.
Who manufactures OMEPRAZOLE DR 10 MG CAPSULE?
OMEPRAZOLE DR 10 MG CAPSULE (NDC 68462039501) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.